There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

The original LuX-Valve system was associated with 10.3% mortality and 4.0% hospitalization for heart failure at 1 year when ...

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.